The toxic mess at Credit Suisse
Swiss regulators are escalating an investigation into a corporate espionage scandal at Credit Suisse.
Swiss regulators announced last week that they were escalating an investigation into a corporate espionage scandal at Credit Suisse, says Kalyeena Makortoff in The Guardian. Credit Suisse has already admitted hiring private detectives to track two former executives: Iqbal Khan, the former head of the bank’s wealth management division, and former head of human resources Peter Goerke. While Credit Suisse has tried to reassure investors that the scandal has not affected its business, it has already been forced to sack chief operating officer Pierre-Olivier Bouée, while CEO Tidjane Thiam (pictured) was forced to resign.
The scandal is unlikely to hurt the bank’s bottom line, since Swiss regulators don’t have the power to issue fines, say Harry Dempsey and Owen Walker in the Financial Times. But this is just the latest in a “series of revelations” about the group’s involvement in “risky business”, which also includes its exposure to the collapse of fraudulent German payments group Wirecard.
The spying scandal raises “wider questions” about governance and a “toxic culture” where the board seems to have “lost control”, says Lucy Burton in The Daily Telegraph. One person “who might have the answers” about how to move on from such problems is Richard Meddings, who was appointed to Credit Suisse’s board of director in April. Meddings has been involved with trying to deal with the fallout of scandals at Deutsche Bank, which was fined $7bn by US authorities, and TSB, which was involved with “one of the sector’s worst IT meltdowns in recent history
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
-
Should you invest in Canada?
Canada presents a compelling opportunity for investors who want to look beyond the US. Greg Eckel of Canadian General Investments highlights four favourites
By Greg Eckel Published
-
Higher rates are disappearing – should you fix your savings?
Fixed savings rates have dropped to their lowest levels in over a year. Should you fix your savings now ahead of a potential base rate cut in November?
By Katie Williams Published
-
What will a broken-up Google look like?
The US courts have ruled that Google is a monopoly, leaving it facing the prospect of a break-up. WIll that be a good thing?
By Matthew Lynn Published
-
How will the UK gambling sector be hit by the Budget?
There are concerns for the UK gambling sector in the lead-up to the Autumn Budget. What could be on the cards?
By Dr Matthew Partridge Published
-
HSBC returns to cost-cutting plan
HSBC is set to revamp its commercial banking division – but will it come at a cost?
By Dr Matthew Partridge Published
-
Pfizer shares rise as US investor takes $1 billion stake
Pfizer shares are on the up since US activist investor Starboard Value built up a stake in the drug maker. But strategic options appear limited
By Dr Matthew Partridge Published
-
Qualcomm could acquire rival Intel – but securing the deal won't be easy
A tie-up between Qualcomm and its semiconductor rival Intel would be a coup. But multiple regulatory and commercial hurdles lie ahead.
By Dr Matthew Partridge Published
-
Modi’s reforms set Indian stocks on fire
Indian stocks pass a new milestone, but global fund managers are holding back. Are there signs of overheating?
By Alex Rankine Published
-
How to invest in the quiet market months
Here's how to invest in the quiet market months, since “sell in May” hasn’t paid off this year.
By Cris Sholto Heaton Published
-
Spire Healthcare: invest in the booming demand for private healthcare
Spire Healthcare is one of the few listed companies benefiting from the growing trend in private healthcare. Should you invest?
By Rupert Hargreaves Published